Sufentanil Citrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sufentanil Citrate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 05/03/2022. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 17478-050-02
- Dosage Form
- Injection
- Presentation
- Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)
- Initial Posting
- 05/03/2022
- Revised Date
Reason
Other